Clinical and Experimental Reproductive Medicine-CERM

Scope & Guideline

Empowering Practitioners with Cutting-Edge Insights

Introduction

Delve into the academic richness of Clinical and Experimental Reproductive Medicine-CERM with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2233-8233
PublisherKOREAN SOC REPRODUCTIVE MEDICINE
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 2011 to 2024
AbbreviationCLIN EXP REPROD MED / Clin. Exp. Reprod. Med.-CERM
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCHEIL MED RESEARCH INST BLDG 2F, CHEIL GENREAL HOSP, KWANDONG UNIV, COLL MED, SEOUL 100-380, SOUTH KOREA

Aims and Scopes

The journal "Clinical and Experimental Reproductive Medicine (CERM)" focuses on advancing the scientific understanding of reproductive medicine through a diverse range of studies. Its primary aim is to publish high-quality research that informs clinical practices and enhances reproductive health outcomes.
  1. Reproductive Health Research:
    CERM publishes studies related to reproductive health, including fertility, infertility treatments, and reproductive endocrinology, addressing both male and female reproductive systems.
  2. Innovative Treatment Modalities:
    The journal highlights novel therapeutic approaches and interventions in reproductive medicine, such as the use of stem cells, hormonal therapies, and nutritional supplements.
  3. Clinical and Experimental Studies:
    CERM features both clinical trials and experimental studies, bridging the gap between laboratory research and clinical applications to improve patient care.
  4. Metabolic and Genetic Factors in Reproduction:
    Research on the influence of metabolic syndromes and genetic predispositions on reproductive health is a key focus, exploring how these factors impact fertility and reproductive outcomes.
  5. Environmental and Lifestyle Impacts:
    The journal examines the effects of environmental toxins, lifestyle choices, and public health issues, such as the COVID-19 pandemic, on reproductive health.
CERM has recently seen a surge in research themes that reflect the latest advancements and emerging concerns in reproductive medicine. These trends indicate a shift towards integrating technology, personalized medicine, and holistic approaches to reproductive health.
  1. Metabolomics and Biomarkers:
    Research utilizing metabolomic profiling to identify biomarkers for fertility and reproductive health is on the rise, offering insights into personalized treatment strategies.
  2. Impact of COVID-19 on Reproductive Health:
    The pandemic has prompted increased studies examining the implications of COVID-19 on fertility, reproductive outcomes, and the safety of assisted reproductive technologies.
  3. Nutritional and Supplement Interventions:
    There is a growing emphasis on the role of dietary supplements and nutritional interventions in enhancing fertility and reproductive health, particularly in populations with specific deficiencies.
  4. Artificial Intelligence in Reproductive Medicine:
    The implementation of AI-driven technologies for optimizing IVF procedures and predicting patient outcomes is an emerging trend, showcasing the integration of technology in reproductive practices.
  5. Environmental and Lifestyle Influences:
    Research focusing on the effects of environmental factors, such as pollutants and lifestyle choices on reproductive health, is gaining traction, reflecting a broader awareness of public health issues.

Declining or Waning

While CERM continues to thrive in various research areas, certain themes are becoming less prominent in recent years. This decline may reflect evolving research interests or a shift towards more pressing issues in reproductive medicine.
  1. Traditional Pharmacological Interventions:
    Research focusing on conventional pharmacological treatments for reproductive health issues, such as hormone replacement therapies, appears to be waning as newer, more innovative treatments gain attention.
  2. Animal Model Studies:
    There is a noticeable decrease in studies solely reliant on animal models, indicating a shift towards human-centered research that prioritizes clinical relevance and applicability.
  3. Invasive Surgical Procedures:
    The exploration of invasive surgical techniques for fertility treatments is declining, likely due to advances in less invasive methods and the growing preference for minimally invasive approaches.

Similar Journals

Basic and Clinical Andrology

Transforming research into practice for optimal reproductive health.
Publisher: BMCISSN: Frequency: 1 issue/year

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.

ENDOCRINE RESEARCH

Connecting researchers to the pulse of endocrine science.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

Journal of Ovarian Research

Innovating knowledge for a healthier future in ovarian research.
Publisher: BMCISSN: Frequency: 1 issue/year

The Journal of Ovarian Research, published by BMC, is a premier open access journal dedicated to advancing knowledge in the fields of Obstetrics and Gynecology as well as Oncology. Established in 2008, this journal is based in the United Kingdom and has garnered significant attention, evidenced by its impressive Q1 ranking in Obstetrics and Gynecology and Q2 in Oncology as per the 2023 category quartiles. The journal boasts a notable Scopus ranking, placing it at #32 out of 209 in its primary field, showcasing a staggering 84th percentile ranking, indicating its relevance and impact on ongoing research in these disciplines. By facilitating unrestricted access to high-quality research through its open access model, the Journal of Ovarian Research serves as a vital resource for researchers, clinicians, and students alike, fostering collaboration and innovation in ovarian health studies.

International Journal of Fertility & Sterility

Fostering Collaboration for Fertility Solutions
Publisher: ROYAN INSTISSN: 2008-076XFrequency: 4 issues/year

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

GYNECOLOGICAL ENDOCRINOLOGY

Unlocking New Horizons in Gynecological Science
Publisher: TAYLOR & FRANCIS LTDISSN: 0951-3590Frequency: 12 issues/year

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Reproductive Biology and Endocrinology

Advancing Knowledge in Reproductive Health and Endocrine Science
Publisher: BMCISSN: Frequency: 1 issue/year

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

Hormone Molecular Biology and Clinical Investigation

Exploring the Frontiers of Hormonal Science
Publisher: WALTER DE GRUYTER GMBHISSN: 1868-1883Frequency: 12 issues/year

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Gynakologische Endokrinologie

Elevating Clinical Practices in Endocrinology and Gynecology
Publisher: SPRINGER HEIDELBERGISSN: 1610-2894Frequency: 4 issues/year

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Gynakologie

Exploring the forefront of obstetrics and gynecology.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7102Frequency: 12 issues/year

Gynakologie is a specialized academic journal published by Springer Heidelberg, focusing on the dynamic field of obstetrics and gynecology. With an ISSN of 2731-7102 and an E-ISSN of 2731-7110, the journal aims to provide a platform for innovative research and discussions that contribute significantly to women's health. Launched in 2022 and set to converge by 2024, it has quickly established itself within the academic community, currently ranking in the Q4 category in Obstetrics and Gynecology as per the 2023 quartile assessments. Despite its current positioning, the journal is dedicated to enhancing visibility and scholarly impact in this essential medical field. Published in Germany, it plays an important role in disseminating valuable insights and findings among researchers, clinicians, and students alike, thus fostering a better understanding of women's health issues. While the journal currently lacks open access options, it remains committed to contributing to the body of knowledge and advancing practices that benefit patients worldwide.

World Journal of Mens Health

Empowering knowledge for a healthier tomorrow.
Publisher: KOREAN SOC SEXUAL MEDICINE & ANDROLOGYISSN: 2287-4208Frequency: 4 issues/year

World Journal of Men's Health, published by the Korean Society for Sexual Medicine and Andrology, stands at the forefront of research in urology, reproductive medicine, and public health. This open-access journal, which has been serving the global medical community since 2011, provides a platform for high-quality, peer-reviewed articles spanning various disciplines, including aging, health policy, and pharmacology. With impressive rankings in multiple categories—such as Q1 in Urology and Q2 in Reproductive Medicine—the journal is recognized for its impactful contributions to advancing knowledge and practice. The ISSN 2287-4208 and E-ISSN 2287-4690 ensure its broad visibility and accessibility. The journal's commitment to disseminating vital research findings makes it an essential resource for researchers, practitioners, and students dedicated to improving men's health worldwide. With its editorial office located at Pusan National University Medical School, Dept of Urology, Busan, South Korea, it continues to enrich the academic and clinical landscape.